Glucose and fructose levels were 30 per cent higher after researchers removed two genes that regulate sugar content, ...

Therapies for obesity and inhibitors for lipoprotein(a) (Lp[a]) are among those to be featured at the American Heart ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

Genome Editing Market Size Was Valued at USD 7.39 Billion in 2023, and is Projected to Reach USD 30.78 Billion by 2032, ...

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

I n a groundbreaking study published in the journal Nature, researchers have successfully used gene editing to create sweeter ...

The transplant organ, with 69 genomic edits, was provided to the hospital by eGenesis in Cambridge, from a pig donor that had ...

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, ...

In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for ...

Selection for bigger tomatoes has made the fruits less sweet, but now it has been shown that gene editing can make them ...